| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Chemistry [A. G., S. T., S. R. T., G. N. W.] and Division of Toxicology [S. T., L. J. K., S. R. T., G. N. W.], Massachusetts Institute of Technology, Cambridge, Massachusetts 02139
In SJL mice, growth of RcsX lymphoma cells results in activation of macrophages in the spleen and lymph nodes to produce high levels of NO radical (NO·). We used this experimental model system to study the toxicology of NO· in vivo. To characterize spatial relationships between sites of NO· production and tissue damage, immunohistochemical techniques were developed for simultaneous detection of inducible NO· synthase (iNOS), 3-nitrotyrosine, and apoptosis in spleen and lymph nodes of tumor-bearing animals. Elevated expression of iNOS, presumed to reflect increased NO· production, was associated with a significant increase in frequency of apoptotic nuclei. Both apoptotic nuclei and 3-nitrotyrosine staining were found in cells juxtaposed to iNOS-expressing (i.e., NO·-producing) macrophages and also within the macrophages themselves. To assess the extent of DNA damage associated with the response, 8-oxoguanine levels were quantified in DNA extracted from spleens of tumor-bearing mice. No increase in levels of this marker of oxidative DNA damage was found in tissues in which apoptosis and 3-nitrotyrosine levels were highly elevated within specific subsets of cells. Collectively, our results indicate that under the pathophysiological conditions existing in the RcsX tumor-bearing SJL mouse, cellular damage caused by NO· and/or other reactive species produced by activated macrophages is highly localized within cells in close proximity to the activated macrophages.
1 To whom requests for reprints should be addressed, at Division of Toxicology, Massachusetts Institute of Technology, Room 26-009, Cambridge, MA 02139-4307.
Received 12/10/96. Accepted 4/ 1/97.
This article has been cited by other articles:
|
|
 |
|
  B. Pang, X. Zhou, H. Yu, M. Dong, K. Taghizadeh, J. S. Wishnok, S. R. Tannenbaum, and P. C. Dedon Lipid peroxidation dominates the chemistry of DNA adduct formation in a mouse model of inflammation Carcinogenesis, August 1, 2007; 28(8): 1807 - 1813. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Su, J. Kuball, A.-P. Barreiros, D. Gottfried, E. A. Ferreira, M. Theobald, P. R. Galle, D. Strand, and S. Strand Nitric Oxide Promotes Resistance to Tumor Suppression by CTLs J. Immunol., April 1, 2006; 176(7): 3923 - 3930. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.-E. Hu, S. O. M. Dyke, A. M. Moore, L. L. Thomsen, and K. M. Brindle Tumor Cell-Derived Nitric Oxide Is Involved in the Immune-Rejection of an Immunogenic Murine Lymphoma Cancer Res., January 1, 2004; 64(1): 152 - 161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-C. Souici, J. Mirkovitch, P. Hausel, L. K.Keefer, and E. Felley-Bosco Transition mutation in codon 248 of the p53 tumor suppressor gene induced by reactive oxygen species and a nitric oxide-releasing compound Carcinogenesis, February 1, 2000; 21(2): 281 - 287. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-T. Lin, J.-Y. Xue, M. C. Lin, E. G. Spokas, F. F. Sun, and P. Y.-K. Wong Peroxynitrite induces apoptosis of HL-60 cells by activation of a caspase-3 family protease Am J Physiol Cell Physiol, April 1, 1998; 274(4): C855 - C860. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Zhuang and G. N. Wogan Growth and viability of macrophages continuously stimulated to produce nitric oxide PNAS, October 28, 1997; 94(22): 11875 - 11880. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
